Lolu lwazi lungenzelwe izinjongo zemfundo kuphela. Aluhloselwe ukuba yiseluleko sezokwelapha. Hlala ubonisana nochwepheshe wezempilo ofanelekile.
Incazelo, Umthamo, Imiphumela Engemihle, Izithiyo. Data from EMA, URPL, openFDA and other regulatory sources.
| Salbutamol | Salmeterol | |
|---|---|---|
| Izithako Ezisebenzayo | Salbutamolum | Salmeterolum + Fluticasoni propionas |
| Ikhodi ye-ATC | R03CC02 | R03AK06 |
| Isimo | Tabletki | Proszek do inhalacji, podzielony |
| Umthamo | 4 mg | (50 mikrogramów + 250 mikrogramów)/dawkę |
| Indlela Yokuthatha | doustna | wziewna |
| Umkhiqizi | Zakłady Farmaceutyczne POLPHARMA S.A. | InPharm Sp. z o.o. |
Salbutamol (INN: Salbutamolum, ATC R03CC02) and Salmeterol (INN: Salmeterolum + Fluticasoni propionas, ATC R03AK06) differ in active substance, indications, and safety profile. The table above summarizes the clinical differences from regulatory documents.
Combination safety depends on mechanisms and your health profile. Use our interactions checker and always consult your doctor or pharmacist before combining medications.
Both drugs are approved when used per label. Safety is patient-specific — the better choice depends on your condition, other medications, allergies, and comorbidities. Consult a healthcare professional for personalized advice.
Lolu lwazi lungenzelwe izinjongo zemfundo kuphela. Aluhloselwe ukuba yiseluleko sezokwelapha. Hlala ubonisana nochwepheshe wezempilo ofanelekile.